SPG20 Antikörper (C-Term)
-
- Target Alle SPG20 Antikörper anzeigen
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
-
Bindungsspezifität
- AA 490-519, C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SPG20 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody recognizes Human
- Aufreinigung
- Affinity Chromatography on Protein A
- Immunogen
- KLH conjugated synthetic peptide between 490-519 amino acids from the C-terminal region of Human SPG20 Genename: SPG20
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product SPG20 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS, 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
-
- Target
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
- Andere Bezeichnung
- Spartin / SPG20 (SPG20 Produkte)
- Synonyme
- SPARTIN antikoerper, TAHCCP1 antikoerper, AI840044 antikoerper, C79168 antikoerper, mKIAA0610 antikoerper, spartin antikoerper, Spg20 antikoerper, spg20a antikoerper, zgc:172059 antikoerper, spg20b antikoerper, zgc:153766 antikoerper, spartin antikoerper, spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) antikoerper, spartin a antikoerper, spartin b antikoerper, SPART antikoerper, Spg20 antikoerper, Spart antikoerper, sparta antikoerper, spartb antikoerper
- Hintergrund
- SPG20 is a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome)Synonyms: KIAA0610, Spastic paraplegia 20 protein, TAHCCP1, Trans-activated by hepatitis C virus core protein 1
- Molekulargewicht
- 72833 Da
- Gen-ID
- 23111
- NCBI Accession
- NP_001135766
- Pathways
- Regulation of Cell Size, SARS-CoV-2 Protein Interaktom
-